drugset / Trial / NCT06596668
Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)
NaSingle-groupOpen-labelTreatment
Summary
Researchers have designed a study medicine called bomedemstat (MK-3543) as a new way to treat certain rare blood diseases. The purpose of this study is to learn what happens to bomedemstat in a person's body over time (a pharmacokinetic or PK study). Researchers will compare what happens to bomedemstat in the body when it is given alone and after multiple doses of another medicine called carbamazepine (CBZ).
Timeline
- Start
- 2024-10-02
- Primary completion
- 2025-02-05
- Completion
- 2025-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bomedemstat | Small molecule | — | Oral |
| Subject | Carbamazepine | Small molecule | — | Oral |
Indications
No indication recorded.